Methylnaltrexone

Results: 16



#Item
1NOT FOR IMMEDIATE RELEASE  SHIONOGI & CO., LTD ANNOUNCES THAT NALDEMEDINE MEETS PRIMARY ENDPOINT IN A PHASE 3 STUDY FOR THE TREATMENT OF OPIOID-INDUCED CONSTIPATION FLORHAM PARK, NJ (March 30, 2015) – Naldemedine, an i

NOT FOR IMMEDIATE RELEASE SHIONOGI & CO., LTD ANNOUNCES THAT NALDEMEDINE MEETS PRIMARY ENDPOINT IN A PHASE 3 STUDY FOR THE TREATMENT OF OPIOID-INDUCED CONSTIPATION FLORHAM PARK, NJ (March 30, 2015) – Naldemedine, an i

Add to Reading List

Source URL: shionogi616.tew-staging.com

Language: English - Date: 2015-04-27 07:57:32
2Needham & Company 2015 Healthcare Conference Stephen Doberstein, Ph.D. Senior Vice President & Chief Scientific Officer  April 15, 2015

Needham & Company 2015 Healthcare Conference Stephen Doberstein, Ph.D. Senior Vice President & Chief Scientific Officer April 15, 2015

Add to Reading List

Source URL: www.nektar.com

Language: English - Date: 2015-04-15 08:48:13
3Managing_Opioid-Induced_Constipation

Managing_Opioid-Induced_Constipation

Add to Reading List

Source URL: www.2ndchance.info

Language: English - Date: 2014-02-04 18:20:56
4Methylnaltrexone (Relistor®) A novel treatment for opioid-induced constipation http://www.healthandherbs.co.nz/Health-Library/Digestion--Gastrointestinal-Health/Resveratrol-for-Digestive-Health/default.aspx  Heather A.

Methylnaltrexone (Relistor®) A novel treatment for opioid-induced constipation http://www.healthandherbs.co.nz/Health-Library/Digestion--Gastrointestinal-Health/Resveratrol-for-Digestive-Health/default.aspx Heather A.

Add to Reading List

Source URL: www.utexas.edu

Language: English - Date: 2010-12-16 08:31:43
5TXT_PI_US_Relistor_20mg/mL Injectable_4.0

TXT_PI_US_Relistor_20mg/mL Injectable_4.0

Add to Reading List

Source URL: cdn.salix.com

Language: English - Date: 2014-10-06 12:28:23
6Giazo Patient Information Form_0412

Giazo Patient Information Form_0412

Add to Reading List

Source URL: cdn.salix.com

Language: English - Date: 2014-11-10 12:16:17
7Cardiovascular Assessment of Peripherally Active Mu-Opioid Antagonists Donna Griebel, M.D. Division of Gastroenterology and Inborn Errors Products June 11, 2014

Cardiovascular Assessment of Peripherally Active Mu-Opioid Antagonists Donna Griebel, M.D. Division of Gastroenterology and Inborn Errors Products June 11, 2014

Add to Reading List

Source URL: www.fda.gov

Language: English
8Kentucky Department for Medicaid Services

Kentucky Department for Medicaid Services

Add to Reading List

Source URL: chfs.ky.gov

Language: English - Date: 2014-11-28 00:41:41
9C-1  Alvimopan— Retrospective Evaluation of Opioid Withdrawal and Cardiovascular Safety With Long-term Use in Opioid-Induced Constipation

C-1 Alvimopan— Retrospective Evaluation of Opioid Withdrawal and Cardiovascular Safety With Long-term Use in Opioid-Induced Constipation

Add to Reading List

Source URL: www.fda.gov

Language: English
10Microsoft PowerPoint - AADPAC_Salix Presentation_Show FIle.pptx

Microsoft PowerPoint - AADPAC_Salix Presentation_Show FIle.pptx

Add to Reading List

Source URL: www.fda.gov

Language: English